EMEA-001999-PIP02-17-M01

Key facts

Active substance
Cenicriviroc
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0356/2020
PIP number
EMEA-001999-PIP02-17-M01
Pharmaceutical form(s)
  • Age-appropriate oral liquid dosage form
  • Film-coated tablet
Condition(s) / indication(s)
Treatment of non-alcoholic steatohepatitis (NASH)
Route(s) of administration
Oral use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

E-mail: UK_Medinfo@allergan.com
Tel: +44 1628494026

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating